• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    9/3/25 1:04:21 PM ET
    $TIRX
    Specialty Insurers
    Finance
    Get the next $TIRX alert in real time by email
    6-K 1 tm2525153d1_6k.htm FORM 6-K

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of September 2025

     

    Commission File Number: 001- 39925

     

    TIAN RUIXIANG Holdings Ltd

     

    Room 918, Jingding Building,

    Xicheng District, District, Beijing,

    People’s Republic of China

    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F x       Form 40-F ¨

     

     

     

     

     

    INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

     

    Information on the Reverse Share Split

     

    On September 2, 2025, the Company announced a reverse stock split of its ordinary shares at a ratio of five (5) to one (1), the par value of the Company’s Class A and Class B ordinary shares will be increased from US$0.025 per share to US$0.125 per share.(the “Reverse Share Split”). The Reverse Share Split will become effective as of September 5, 2025 (the “Effective Date”). The Company’s ordinary shares will begin trading on a split-adjusted basis when the Nasdaq Global Market (“Nasdaq”) opens for trading at 9:00 a.m. EST on Friday, Sepetmber 5, 2025 under the existing trading symbol “TIRX,” but the ordinary shares will trade under a new CUSIP number, G8884K136. A copy of the press release announcing the Reverse Share Split is attached to this Form 6-K as Exhibit 99.1.

     

     

     

     

    EXHIBIT INDEX

     

    Exhibit No.   Description
         
    99.1   Press Release dated September 2, 2025

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      TIAN RUIXIANG Holdings Ltd
         
    Date: September 3, 2025 By: /s/ Baohai Xu
      Name: Baohai Xu
      Title: Chief Executive Officer

     

     

     

    Get the next $TIRX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TIRX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $TIRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TIAN RUIXIANG Holdings Ltd. Announces Reverse Stock Split with Marketplace Effective Date on September 5, 2025

    BEIJING, Sept. 02, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd. (NASDAQ:TIRX) (the "Company") today announced that it will implement a reverse stock split of its ordinary shares at a ratio of five (5) to one (1), The Company's ordinary shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market at that time under the same ticker symbol, TIRX, effective at the open of business on September 5, 2025. As part of the reverse stock split, the par value of the Company's Class A and Class B ordinary shares will be increased from US$0.025 per share to US$0.125 per share. No fractional shares will be issued in connection with the reverse stock split, and any fractional

    9/2/25 8:00:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    Water Tower Research Publishes Initiation of Coverage Report on Tian Ruixiang Holdings Limited, "From Traditional Insurance Broker to Tech-Based Health Insurance Innovator"

    ST. PETERSBURG, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Tian Ruixiang Holdings Limited (NASDAQ:TIRX) titled, "From Traditional Insurance Broker to Tech- Based Health Insurance Innovator". The report can be accessed here. Access to China's growing health insurance market. On June 30, 2025, Chinese insurance broker Tian Ruixiang Holdings Limited completed the acquisition of Ucare, which describes itself as the only cloud-based healthcare value assessment and insurance risk control SaaS platform in China, for total all-stock consideration of $150 million. Ucare's wealth of AI-driven analytics st

    8/7/25 12:00:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Completes Acquisition of Ucare Inc., Marking Strategic Expansion into AI-Powered Health Insurance Solutions

    BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced it has completed the acquisition of 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform. The all-stock transaction, valued at US$150 million, marks a major milestone in TRX's strategy to expand into in-hospital distribution channels and capture new growth opportunities within the health insurance sector. As part of the closing, TRX has issued 101,486,575 Class A ordinary shares, each with a par value of US$0.025

    6/30/25 3:05:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    SEC Filings

    View All

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    9/3/25 1:04:21 PM ET
    $TIRX
    Specialty Insurers
    Finance

    Amendment: SEC Form 6-K/A filed by TIAN RUIXIANG Holdings Ltd

    6-K/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    8/29/25 4:12:47 PM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    8/26/25 4:45:22 PM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Leadership Updates

    Live Leadership Updates

    View All

    TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy

    BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wholly-owned subsidiary, VitaCare Limited ("VitaCare") have entered into a share exchange agreement (the "Agreement") with certain shareholders (the "Sellers") of Ucare and other parties.

    5/30/25 6:10:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by TIAN RUIXIANG Holdings Ltd

    SC 13G/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    11/13/24 11:16:48 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SC 13D filed by TIAN RUIXIANG Holdings Ltd

    SC 13D - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    6/10/24 6:15:45 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by TIAN RUIXIANG Holdings Ltd (Amendment)

    SC 13D/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    6/10/24 6:08:20 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Financials

    Live finance-specific insights

    View All

    Water Tower Research Publishes Initiation of Coverage Report on Tian Ruixiang Holdings Limited, "From Traditional Insurance Broker to Tech-Based Health Insurance Innovator"

    ST. PETERSBURG, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Tian Ruixiang Holdings Limited (NASDAQ:TIRX) titled, "From Traditional Insurance Broker to Tech- Based Health Insurance Innovator". The report can be accessed here. Access to China's growing health insurance market. On June 30, 2025, Chinese insurance broker Tian Ruixiang Holdings Limited completed the acquisition of Ucare, which describes itself as the only cloud-based healthcare value assessment and insurance risk control SaaS platform in China, for total all-stock consideration of $150 million. Ucare's wealth of AI-driven analytics st

    8/7/25 12:00:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Completes Acquisition of Ucare Inc., Marking Strategic Expansion into AI-Powered Health Insurance Solutions

    BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced it has completed the acquisition of 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform. The all-stock transaction, valued at US$150 million, marks a major milestone in TRX's strategy to expand into in-hospital distribution channels and capture new growth opportunities within the health insurance sector. As part of the closing, TRX has issued 101,486,575 Class A ordinary shares, each with a par value of US$0.025

    6/30/25 3:05:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Reports Financial Results for the Half Year Ended April 30, 2024

    BEIJING, Aug. 16, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced its financial results for the half year ended April 30, 2024. Ms. Sheng Xu, the Chief Executive Officer of the Company, commented, "The Company reported a net loss of approximately $2.6 million for the six months ended April 30, 2024, primarily due to a significant decline in revenue caused by the loss of a few key insurance company partners. However, we are encouraged by the increase in the commissions from liability insurance of approximately $24,000 compared to t

    8/16/24 4:15:15 PM ET
    $TIRX
    Specialty Insurers
    Finance